PFF Summit 2017 CME/CE
Title of activity: PFF Summit 2017
Date and location of activity: November 9-11, 2017; Nashville, TN
This activity is jointly provided by Postgraduate Institute for Medicine and the Pulmonary Fibrosis Foundation, in collaboration with Global Academy for Medical Education.
This live meeting is not supported by educational grants.
This activity is intended for physicians, physician’s assistants, respiratory therapists, pharmacists, nurse practitioners, and registered nurses engaged in the care of patients with pulmonary fibrosis.
After completing this activity, the participant should be better able to:
- Explain the pathophysiology of idiopathic pulmonary fibrosis (IPF) based on the most current data
- Accurately diagnose IPF using a systematic approach
- Effectively implement key diagnostic procedures including HRCT scanning and surgical lung biopsy
- Discuss recent evidence for treatments in the management of IPF
- Recognize components of IPF
- Describe the role of lung transplantation in IPF, and the factors that affect candidacy and timing
- Provide patient lifestyle management tools which improve functional status
- Develop a comprehensive approach to the management of IPF, that includes both pharmacologic and non-pharmacologic therapies
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint of Postgraduate Institute for Medicine and the Pulmonary Fibrosis Foundation. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Pharmacy Education
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Postgraduate Institute for Medicine designates this continuing education activity for 16.0 contact hour(s) (1.60 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Numbers
- 0809-9999-17-597-L01-P; 4.75 hours (community pulmonologists and ILD fellows)
- 0809-9999-17-598-L01-P; 1.5 hours (genetics of ILD)
- 0809-9999-17-599-L01-P; 1.5 hours (environmental influences)
- 0809-9999-17-600-L01-P; 1.5 hours (disease mechanisms I)
- 0809-9999-17-601-L01-P; 1.25 hours (therapeutics)
- 0809-9999-17-602-L01-P; 1.5 hours (disease mechanisms II)
- 0800-9999-17-708-L01-P; 2.0 hours (plenary session I)
- 0809-9999-17-709-L01-P; 2.0 hours (plenary session II)
Type of Activity: Knowledge
Continuing Nursing Education
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 17.5 contact hours is provided by Postgraduate Institute for Medicine. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.
Continuing Respiratory Therapist Education
This program has been approved for 16.99 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425, N. MacArthur Blvd, Suite 100, Irving TX 75063.
Respiratory Therapists must sign the Attendance log for each and must complete the online evaluation within 30 days of the end of the activity to obtain AART credit.
How to Obtain Credit
Please go online to CME University www.cmeuniversity.com and register or login (takes less than 1 minute).
Once logged into CME University, follow these steps:
1. Click on the “Find Post-Test/Evaluation by Course:” at the top of the page.
2. Type in “12206” and hit enter.
3. Click on the Activity Title.
4. Choose your profession/type of credit you are seeking.
5. Complete the online Evaluation Form.
Upon completion of the online Evaluation form, you will have immediate access to a certificate of attendance to print or save for your files.
If you have any questions regarding the CME/CE certification for this activity, please contact Institute for Medicine email@example.com or (303) 799-1930.
For Pharmacists and Respiratory Therapists – the evaluation must be completed online within 30 days of the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Disclosure of Unlabeled Use
This educational activity may contain published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Jeri Webb prior to the live event at firstname.lastname@example.org.
A statement of credit will be issued immediately upon completing the evaluation on the CME University website.
Upon completing the evaluation at CME University, your transcript information will be sent to the NABP CPE Monitor Service.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Key Takeaways From the IPF Experts at the PFF Summit 2017
Supported by educational grants Genentech and Boehringer Ingelheim
Available Credits: 1.0 AMA PRA Category 1 Credits™
This activity is intended for pulmonologists, family practitioners, internists, nurse practitioners, physician assistants, and other clinicians who treat patients with idiopathic pulmonary fibrosis (IPF).
Released: December 20, 2017
Expires: December 20, 2018